1. Home
  2. ORIC vs GSRT Comparison

ORIC vs GSRT Comparison

Compare ORIC & GSRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • GSRT
  • Stock Information
  • Founded
  • ORIC 2014
  • GSRT 2023
  • Country
  • ORIC United States
  • GSRT United States
  • Employees
  • ORIC N/A
  • GSRT N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • GSRT
  • Sector
  • ORIC Health Care
  • GSRT
  • Exchange
  • ORIC Nasdaq
  • GSRT Nasdaq
  • Market Cap
  • ORIC 362.9M
  • GSRT 316.5M
  • IPO Year
  • ORIC 2020
  • GSRT 2024
  • Fundamental
  • Price
  • ORIC $10.05
  • GSRT $10.89
  • Analyst Decision
  • ORIC Strong Buy
  • GSRT
  • Analyst Count
  • ORIC 8
  • GSRT 0
  • Target Price
  • ORIC $18.83
  • GSRT N/A
  • AVG Volume (30 Days)
  • ORIC 1.3M
  • GSRT 1.4M
  • Earning Date
  • ORIC 08-11-2025
  • GSRT 01-01-0001
  • Dividend Yield
  • ORIC N/A
  • GSRT N/A
  • EPS Growth
  • ORIC N/A
  • GSRT N/A
  • EPS
  • ORIC N/A
  • GSRT 0.14
  • Revenue
  • ORIC N/A
  • GSRT N/A
  • Revenue This Year
  • ORIC N/A
  • GSRT N/A
  • Revenue Next Year
  • ORIC N/A
  • GSRT N/A
  • P/E Ratio
  • ORIC N/A
  • GSRT $76.41
  • Revenue Growth
  • ORIC N/A
  • GSRT N/A
  • 52 Week Low
  • ORIC $3.90
  • GSRT $9.86
  • 52 Week High
  • ORIC $14.67
  • GSRT $11.49
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 63.99
  • GSRT N/A
  • Support Level
  • ORIC $10.05
  • GSRT N/A
  • Resistance Level
  • ORIC $10.99
  • GSRT N/A
  • Average True Range (ATR)
  • ORIC 0.60
  • GSRT 0.00
  • MACD
  • ORIC -0.07
  • GSRT 0.00
  • Stochastic Oscillator
  • ORIC 54.67
  • GSRT 0.00

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

About GSRT GSR III Acquisition Corp. Ordinary Shares

GSR III Acquisition Corp is a blank check company.

Share on Social Networks: